Mayo Clinic BioPharma Diagnostics to attend Drug Information Association's 2022 meeting

Mayo Clinic BioPharma Diagnostics executives will attend the upcoming Drug Information Association (DIA) annual meeting in Chicago June 19–23 to share with attendees the clinical and research capabilities of Mayo Clinic BioPharma Diagnostics.

Mayo Clinic BioPharma Diagnostics offers clinical research partners unparalleled experience and insights to accelerate projects across the spectrum of clinical and research testing initiatives. Mayo Clinic BioPharma Diagnostics currently supports more than 600 active clinical trial engagements, bringing Mayo Clinic expertise and quality to every project.

While at DIA, our BioPharma business partnership executives will be available to discuss the research and diagnostic needs of prospective partners. Dedicated to changing medicine through interdisciplinary collaboration, Mayo Clinic BioPharma Diagnostics provides partners with access to:

  • More than 150 years of clinical expertise and 50 years of research and testing experience.
  • A large and diverse test menu spanning the full range of subspecialties.
  • Specialty testing leaders to guide understanding of each test, test selection, and results interpretation.
  • Committed, timely, and consistent support at every clinical trial phase.
  • Highest quality standards, including extensive experience providing logistics and courier support.

Sign up here to connect with Mayo Clinic BioPharma Diagnostics at DIA 2022.

Samantha Rossi (@srossi3)

Samantha Rossi